Search results
AP source: J&J doses to be released, but many will be tossed
AOL· 4 days agoU.S. regulators are allowing for the release of 10 million doses of Johnson & Johnson's COVID-19 ...
Janssen adopts J&J name as part of global rebranding effort
Pharmaceutical Technology via Yahoo Finance· 3 days agoPreviously known as GlaxoSmithKline, the drugmaker is now known only by its acronym. J&J reported...
Cidara buys back rights to flu therapy from J&J for $85m
Pharmaceutical Technology via Yahoo Finance· 1 week ago"Cidara buys back rights to flu therapy from J&J for $85m" was originally created and published by...
Big Pharma's Blockbuster Creation Continues to Disappoint
Mercola· 1 week agoMessenger ribonucleic acid (mRNA) vaccines are being described as a "new era in vaccinology."1 Research is underway to develop mRNA shots for not only coronaviruses but also ...
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks via Yahoo Finance· 3 days agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 1 week agoThe European Commission (“EC”) approved J&J’s JNJ Carvykti for earlier lines of treatment in...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe pharma giant ranked third in terms of R&D expenditure, investing approximately $15.1bn—a record-breaking figure for the company. However, the company...
Cidara regains rights to flu med after Janssen makes good on promise to divest
FierceBiotech· 1 week agoIn September 2023, Cidara said Janssen had elected to proceed with CD388, triggering a $7 million...
FDA finalizes lab test regulations with more flexibility
Politico· 4 days agoThe agency said the company, Razer Inc., advertised its Zephyr masks as equivalent to N95 respirators without seeking federal certification. CHIKUNGUNYA VACCINE SUBMISSION ...
News Highlights: Top Company News of the Day - Wednesday at 7 AM ET
Morningstar· 3 days agoCVS Made a Big Bet on Medicare. It's Looking Risky. The company's Medicare business, hit by higher medical costs, pushed down CVS's first-quarter earnings. J&J Asks for Votes ...
